BRCA1 and BRCA2 Genetic Testing
J9 · Effective Apr 11, 2016
115 active Medicare policies list C50.929, and 26 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
Showing 100 of 115
J9 · Effective Apr 11, 2016
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J6 · Effective Apr 1, 2019
JK · Effective Apr 1, 2019
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
26 policies from 4 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Showing 10 of 22 · All Aetna policies
| Policy | Effective | Status of C50.929 |
|---|---|---|
| Bevacizumab for Non-Ocular Indications | Feb 20, 2024 | Covered |
| Brachytherapy | Jun 6, 2023 | Covered |
| Breast Biopsy Procedures | Apr 26, 2023 | Covered |
| Breast Ductal Lavage and Fiberoptic Ductoscopy | Jul 12, 2023 | Covered |
| Breast Reconstructive Surgery | Apr 7, 2023 | Covered |
| Breast Transillumination, Electrical Impedance Scanning (EIS), and Elastography | Dec 5, 2023 |
JJ · Effective Feb 19, 2023
JM · Effective Feb 19, 2023
J15 · Effective Aug 21, 2022
JE · Effective Aug 8, 2022
JF · Effective Aug 8, 2022
JJ · Effective Jul 3, 2022
JM · Effective Jul 3, 2022
J5 · Effective Jul 3, 2022
J8 · Effective Jul 3, 2022
J15 · Effective Dec 26, 2021
JE · Effective Jan 2, 2022
JF · Effective Jan 2, 2022
JJ · Effective Dec 26, 2021
JM · Effective Dec 26, 2021
J5 · Effective Dec 26, 2021
J8 · Effective Dec 26, 2021
J15 · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Feb 16, 2017
J8 · Effective Feb 16, 2017
J15 · Effective Feb 10, 2020
JE · Effective May 17, 2020
JF · Effective May 17, 2020
JJ · Effective Feb 10, 2020
JM · Effective Feb 10, 2020
J5 · Effective Feb 9, 2020
J8 · Effective Feb 9, 2020
J15 · Effective Jul 27, 2020
JE · Effective Dec 26, 2022
JF · Effective Dec 26, 2022
JJ · Effective Feb 3, 2020
JM · Effective Feb 3, 2020
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J6 · Effective Jul 13, 2025
JK · Effective Jul 13, 2025
J9 · Effective Dec 12, 2021
JH · Effective Dec 12, 2021
JL · Effective Dec 12, 2021
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JJ · Effective Nov 12, 2023
JM · Effective Nov 12, 2023
JJ · Effective Jun 12, 2017
JM · Effective Jun 12, 2017
J6 · Effective Apr 1, 2026
J6 · Effective Jul 1, 2026
J9 · Effective Oct 1, 2025
J6 · Effective Oct 1, 2026
National · Effective Nov 16, 2023
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2025
National · Effective Oct 1, 2024
National · Effective Oct 1, 2024
National · Effective Feb 19, 2026
J5 · Effective Aug 27, 2026
National · Effective Oct 12, 2026
National · Effective Oct 12, 2026
National · Effective Oct 12, 2026
National · Effective Oct 12, 2026
National · Effective Aug 6, 2026
National · Effective Aug 13, 2026
National · Effective Aug 6, 2026
J5 · Effective Aug 6, 2026
National · Effective Aug 6, 2026
National · Effective Mar 12, 2026
National · Effective Aug 6, 2026
J5 · Effective Aug 6, 2026
National · Effective Sep 24, 2026
J5 · Effective Sep 24, 2026
National · Effective Sep 24, 2026
National · Effective Sep 24, 2026
National · Effective Oct 12, 2026
National · Effective Oct 12, 2026
National · Effective Oct 12, 2026
National · Effective Oct 12, 2026
National · Effective Oct 24, 2019
National · Effective Nov 22, 2023
National · Effective Feb 19, 2026
J5 · Effective Jan 1, 2026
National · Effective Jan 1, 2022
| Covered |
| Cryoablation | Dec 5, 2023 | Covered |
|---|
| Cryoanalgesia and Therapeutic Cold | Mar 16, 2023 | Covered |
|---|
| Flow Cytometry, Ektacytometry, DNA Ploidy, and S-phase Fraction | Jun 5, 2023 | Covered |
|---|
| Genetic Testing | Feb 27, 2024 | Covered |
|---|
| Policy | Effective | Status of C50.929 |
|---|---|---|
| Concert Genetic Testing Oncology: Algorithmic Assays | Not recorded | Referenced |
| Concert Genetic Testing: Toxicology and Pharmacogenetics Version B | Not recorded | Referenced |
| Policy | Effective | Status of C50.929 |
|---|---|---|
| Mastectomy for Gynecomastia | Apr 15, 2026 | Covered |
| Policy | Effective | Status of C50.929 |
|---|---|---|
| Low-Level Laser and High-Power Laser Therapy | Mar 15, 2026 | Covered |